Incellipan is a [pandemic preparedness vaccine](https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/pandemic-influenza/vaccines-pandemic-influenza) used to protect adults and children against influenza (flu). It can only be used during a pandemic declared officially by the World Health Organization (WHO) or within the European Union (EU). A pandemic occurs when a strain of flu can spread easily from person to person because people have no immunity (protection) against it. Incellipan contains small amounts of proteins from the influenza virus. The virus has been inactivated so that it does not cause any disease in people who receive the vaccine.
Therapeutic Indication
### Therapeutic indication Incellipan is indicated for active immunisation against influenza in an officially declared pandemic. Incellipan should be used in accordance with official recommendations.
Therapeutic Area (MeSH)
ATC Code
J07BB02
ATC Item
influenza, inactivated, split virus or surface antigen
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen | N/A | influenza virus a/turkey/turkey/1/2005 (h 5 n 1) nibrg-23 strain, ha surface antigen |
EMA Name
Incellipan
Medicine Name
Incellipan
Aliases
N/ANo risk management plan link.
